COMPOSITION PHARMACEUTIQUE QUI COMPREND UN ACIDE 2,5 - DIHYDROXYBENZÈNOSULPHONIQUE OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES EN FORME D'UNITÉS INDIVIDUALISÉES D'ADMINISTRATION ET PROCÉDÉ DE FABRICATION CORRESPONDANT
Pharmaceutical composition comprising 2,5-dihydroxybenzenesulfonic acid or a pharmaceutically acceptable salt thereof in the form of personalised supply units and the corresponding manufacturing method. Pharmaceutical composition comprising 2,5-dihydroxybenzenesulfonic acid or a pharmaceutically acceptable salt thereof in the form of personalised supply units, in which part of the 2,5-dihydroxybenzenesulfonic acid is in the form of an immediate-release composition additionally comprising between 8% and 28% microcrystalline cellulose, and the other part of which is in the form of a prolonged-release composition additionally comprising between 10% and 45% hydroxypropylmethylcellulose and between 6.1% and 20% hydroxypropylcellulose. The proportion between the two parts is between 24:76 and 40:60. This allows administration of the composition to the patient once every 24 hours. The composition can be used to treat primary varicose states, chronic venous insufficiency, phlebitis, thrombophlebitis, post-thrombotic syndrome, leg ulcers, pregnancy-related varicose veins. as a coadjuvant for varicectomy, sclerotherapy or as a coadjuvant in the treatment of diabetic retinopathy.Composición farmacéutica que comprende ácido 2,5 – dihidroxibencenosulfónico o una de sus sales farmacéuticamente aceptables en forma de unidades individualizadas de suministro y procedimiento de fabricación correspondiente. Composición farmacéutica que comprende ácido 2,5 – dihidroxibencenosulfónico o una de sus sales en forma de unidades individualizadas de suministro, en la que una parte del ácido 2,5 – dihidroxibencenosulfónico está en forma de composición de liberación inmediata, que comprende, adicionalmente entre un 8% a 28% de celulosa microcristalina, y otra parte está en forma de composición de liberación prolongada, que comprende, adicionalmente entre un 10% a 45% de hidroxipropilmetilcelulosa y entre un 6,1% a 20% de hidroxipropilcelulosa. La proporción entre las dos partes está comprendida
